The European Patients' Academy Proudly Announces the Start of the First Patient Expert Training Course
EUPATI welcomes 53 participants to educational program on medicines' R&D
The European Patients’ Academy (EUPATI) is proud to announce the start of the first Patient Expert Training Course. This is one of EUPATI’s key educational programmes specifically designed to meet the needs of patients and patient representatives and to impart expert-level knowledge about the whole spectrum of the medicine research and development process. Last week, a webinar marked the official opening of the Course and the launch of the online learning programs for 53 participants.
“We are excited to start the first Patient Expert Training Course. This unique EUPATI educational program offers patients and patient representatives training across the medicine research and development process. The Course is specifically designed to meet the needs of participants who are motivated with the skill set to acquire and apply this expert-level knowledge,” said Jan Geissler, EUPATI Director.
The EUPATI Patient Expert Training Course is a mixture of online and face-to-face training and covers all aspects of the medicine research and development process including discovery, development, evaluation, marketing authorization and post-marketing evaluation. Over the 15-month training period, participants will take six e-learning modules covering a broad range of topics. Participants will also attend two face-to-face training events for interactive teaching as well as the opportunity to meet directly with other patient experts and with specialists working in the field of medicine development.
The Patient Expert Training Course aims to encourage participants to apply knowledge and skills acquired through three main areas:
- Patient Representation: EUPATI Patient Experts will be able to actively engage in representing a patient perspective in the medicine development process by interacting with scientific committees, Health Technology Assessment agencies, industry, regulatory bodies, academia and other relevant stakeholders.
- Communication: EUPATI Patient Experts will be able to contribute to raising awareness on patient involvement in medicines’ research and development amongst the patient community and the general public.
- Education/Training: EUPATI Patient Experts will be able to fill the role of facilitators/trainers by engaging in the dissemination of the education and information programs for the patient community and the general public in their countries through their patient communities and networks.
The second wave of the Expert Patient Training Course will start in September 2015. By 2016, there will be over 100 Expert Patients who will be able to share their expertise and help to reach the patient community, raise public awareness and generate dialogue around future patient involvement in the medicine research and development.
About Participant Selection
The selection of participants for the first Patient Expert Training Course (2014-2015) was done via a transparent process:EUPATI received more than 300 applications for the course. An Independent Evaluation Panel selected 53 participants based upon careful examination of all eligible applications against the pre-defined selection criteria. The application period for next year's EUPATI Patient Expert Training Course (2015-2016) will start in spring 2015. Details will be available on the EUPATI website.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
